Bnp Paribas Asset Management Holding S.A. Arcus Biosciences, Inc. Transaction History
Bnp Paribas Asset Management Holding S.A.
- $37.3 Billion
- Q1 2025
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 1,628,019 shares of RCUS stock, worth $16.3 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,628,019
Previous 1,521,784
6.98%
Holding current value
$16.3 Million
Previous $22.7 Million
43.6%
% of portfolio
0.03%
Previous 0.06%
Shares
16 transactions
Others Institutions Holding RCUS
# of Institutions
200Shares Held
63.1MCall Options Held
116KPut Options Held
116K-
Black Rock Inc. New York, NY9.76MShares$97.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.69MShares$67.1 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA5.13MShares$51.4 Million0.28% of portfolio
-
State Street Corp Boston, MA3.7MShares$37.1 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.87MShares$28.8 Million0.06% of portfolio
About Arcus Biosciences, Inc.
- Ticker RCUS
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 72,160,000
- Market Cap $724M
- Description
- Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...